Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1423 - MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)

    Primary Author / Presenter(s)

  • KJ

    Krzysztof Jamroziak, MD, PhD

    Professor, Deputy Head of the Department of Hematology
    Medical University of Warsaw
    Warsaw, Poland

    • Co-Author(s)

  • EI

    Elżbieta Iskierka-Jażdżewska, MD, PhD

    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital in Lodz, Poland
    Łódź, Lodzkie, Poland

  • Tadeusz Robak, MD, PhD

    Professor of Hematology; Head, Department of General Hematology & Internal Medicine
    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital
    Łódź, Lodzkie, Poland

  • KZ

    Klaudia Zielonka, MD

    Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw
    Warsaw, Mazowieckie, Poland

  • SG

    Sebastian Giebel, MD, PhD

    Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch
    Gliwice, Slaskie, Poland

  • KW

    Kamil Wisniewski, MD, PhD

    Department of Hematology, Instutute of Hematology and Transfusion Medicine
    Warsaw, Mazowieckie, Poland

  • JD

    Joanna E. Drozd-Sokolowska, MD, PhD

    assistant professor
    Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw
    Warsaw, Mazowieckie, Poland

  • JR

    Justyna Rybka, MD, PhD

    Clinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University
    Wroclaw, Dolnoslaskie, Poland

  • WP

    Weronika Piszczek, MD

    Hematology Department, Rydygier Provincial Polyclinical Hospital in Torun
    Torun, Kujawsko-Pomorskie, Poland

  • MJ

    Monika Joks, MD, PhD

    Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences
    Poznan, Wielkopolskie, Poland

  • AD

    Anna Dabrowska-Iwanicka, MD, PhD

    Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology
    Warsaw, Mazowieckie, Poland

  • AM

    Andrzej Mital, MD, PhD

    Department of Hematology and Transplantology, Medical University of Gdansk
    Gdansk, Pomorskie, Poland

  • PS

    Paweł Steckiewicz, MD, PhD

    Assistant
    Department of Hematology, Holy Cross Cancer Center
    Kielce, Swietokrzyskie, Poland

  • EL

    Ewa Lech-Marańda, MD, PhD

    Department of Hematology, Institute of Hematology and Transfusion Medicine
    Warsaw, Mazowieckie, Poland

  • MJ

    Marcin Jasiński, MD

    Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw
    Warsaw, Mazowieckie, Poland

  • MR

    Marcin Rymko, MD, PhD

    Hematology Department, Rydygier Provincial Polyclinical Hospital in Torun
    Torun, Kujawsko-Pomorskie, Poland

  • DM

    Dawid Marciniak, MD

    Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
    Gliwice, Slaskie, Poland

  • TW

    Tomasz Wrobel, MD, PhD

    Clinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University
    Wroclaw, Dolnoslaskie, Poland

  • LG

    Lidia Gil, MD, PhD

    Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences
    Poznan, Wielkopolskie, Poland

  • JR

    Joanna Romejko-Jarosińska, MD, PhD

    Department of Lymphoid Malignancies, Marie Sklodowska-Curie National Research Institute of Oncology
    Warsaw, Mazowieckie, Poland

  • DK

    Dorota Kruk-Kwapisz, MSc

    Medical University of Warsaw
    Warsaw, Mazowieckie, Poland

  • AC

    Agnieszka Chudy, MSc, PhD

    Laboratory of Genetics, University Clinical Centre of Medical University of Warsaw, Poland
    Warsaw, Mazowieckie, Poland

  • MM

    Marcin Machnicki, MSc, PhD

    Department of Tumor Biology and Genetics, Medical University of Warsaw
    Warsaw, Mazowieckie, Poland

  • Krzysztof Giannopoulos, MD, PhD

    Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
    Lublin, Lubelskie, Poland

  • TS

    Tomasz Stoklosa, MD, PhD

    Department of Tumor Biology and Genetics, Medical University of Warsaw
    Warsaw, Mazowieckie, Poland

  • BP

    Bartosz Pula, MD, PhD

    Hematologist
    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital
    Łódź, Lodzkie, Poland